Article Text

Download PDFPDF
A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component
  1. A. Abe*,
  2. H. Furumoto*,
  3. K. Yoshida*,
  4. M. Nishimura*,
  5. M. Irahara*,
  6. E. Kudo and
  7. T. Sano
  1. *Department of Obstetrics and Gynecology, School of Medicine University of Tokushima, Tokushima, Japan; and
  2. Department of Pathology, School of Medicine University of Tokushima, Tokushima, Japan
  1. Address correspondence and reprint requests to: Akiko Abe, MD, Department of Obstetrics and Gynecology, University of Tokushima, School of Medicine, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan. Email: akiko-a{at}clin.med.tokushima-u.ac.jp

Abstract

Endometrioid adenocarcinoma of the ovary coexists very rarely with yolk sac tumor (YST). This unusual mixed tumor is thought to be a rare variant of endometrioid ovarian carcinoma because of its aggressive behavior, lack of response to chemotherapy, and unfavorable prognosis. We report a case of ovarian endometrioid adenocarcinoma with a YST component in a postmenopausal woman. The patient was treated by surgery and a combination of bleomycin, etoposide, and cisplatin and taxol and carboplatin. She has been clinically free of tumor for 20 months. Immunohistochemically, the YST component reacted for alpha-fetoprotein. YST areas were negative for both CA125 and sex-hormone receptors. Cytokeratin7 and epithelial membrane antigen were negative in YST, but positive in endometrioid adenocarcinoma. The occurrence of this unusual case suggests that even somatic carcinomas may acquire an extraembryonal germ cell differentiation.

  • CK7
  • endometrioid adenocarcinoma
  • epithelial ovarian cancer
  • neometaplasia
  • yolk sac tumor

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.